Cargando…
Intensive care unit outcomes in patients with hematological malignancy
Hematological malignancies are usually life-limiting conditions. Limitations of care need to be decided early, based on acceptability to the patient, family, physician, and community. Inappropriate intensive care unit (ICU) admission is likely to result in significant physical, psychological, and ec...
Autores principales: | Rawson, Jarrod Leigh, Fagan, Fionnuala Mary, Burrough, Georgin Claire, Tang, Helen Michelle, Cuncannon, Moire Alys, Ellem, Katrina Louise, Enjeti, Anoop Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974903/ https://www.ncbi.nlm.nih.gov/pubmed/35399861 http://dx.doi.org/10.1097/BS9.0000000000000038 |
Ejemplares similares
-
Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma
por: Cuncannon, Moire, et al.
Publicado: (2019) -
Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018) -
Incidence and risk of falls in patients treated for hematologic
malignancies in the Intensive Hematology Unit
por: Lorca, Luz Alejandra, et al.
Publicado: (2019) -
Predictors of intensive care unit admission in patients with hematologic malignancy
por: Vijenthira, Abi, et al.
Publicado: (2020) -
Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019)